Armata Pharmaceuticals (ARMP) Enterprise Value Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Armata Pharmaceuticals | 301.92 Mn | 297.17 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 59.33% |
| Dec 31, 2025 | 6.49% |
| Sep 30, 2025 | 13.66% |
| Jun 30, 2025 | 83.72% |
| Mar 31, 2025 | 69.13% |
| Dec 31, 2024 | 31.29% |
| Sep 30, 2024 | 28.45% |
| Jun 30, 2024 | -111.99% |
| Mar 31, 2024 | -50.80% |
| Dec 31, 2023 | 8.95% |
| Sep 30, 2023 | 5.61% |
| Jun 30, 2023 | 66.32% |
| Mar 31, 2023 | 45.90% |
| Dec 31, 2022 | -44.36% |
| Sep 30, 2022 | -110.19% |
| Jun 30, 2022 | -110.87% |
| Mar 31, 2022 | -106.67% |
| Dec 31, 2021 | -6.62% |
| Sep 30, 2021 | 23.98% |
| Jun 30, 2021 | 11.37% |
| Mar 31, 2021 | 7.25% |
| Dec 31, 2020 | -59.94% |
| Sep 30, 2020 | -82.80% |
| Jun 30, 2020 | -49.98% |
| Mar 31, 2020 | -292.88% |
| Dec 31, 2019 | 37.57% |
| Sep 30, 2019 | 35.12% |
| Jun 30, 2019 | 14.47% |
| Mar 31, 2019 | 24.91% |
| Dec 31, 2018 | -88.29% |
| Sep 30, 2018 | -73.37% |
| Jun 30, 2018 | -72.10% |
| Mar 31, 2018 | -272.66% |
| Dec 31, 2017 | 0.00% |
| Sep 30, 2017 | -94.73% |
| Jun 30, 2017 | -25.45% |
| Mar 31, 2017 | 64.33% |
| Dec 31, 2016 | 45.23% |
| Sep 30, 2016 | 66.20% |
| Jun 30, 2016 | 50.22% |